Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Illinois Center for Ophthalmic Drug and Diagnostic Development

ICOD3 logo

The Illinois Center for Ophthalmic Drug and Diagnostic Development (ICOD3) is an initiative of the UI COM Department of Ophthalmology and Visual Sciences focused on accelerating the clinical translation and commercialization of promising technologies.

ICOD3 brings together faculty expertise in all aspects of clinical ophthalmology, basic and translational science with University and external advisors that have experience in intellectual property, entrepreneurship, pre-clinical and clinical stage development.

ICOD3 provides resources for faculty investigators to obtain non-dilutive funding, provide guidance in start-up company formation, development of presentations and grant proposals related to translational activities.

Work With Us Heading link

ICOD3 would love to hear from you! If you are interested in partnering with us, providing help or guidance, have a question about our work or want to support this important endeavor, please let us know.

Email us to start a conversation.

Services Heading link

  • Review

    Review of faculty technologies by experienced entrepreneurs, translational scientists, IP experts, experienced private and public fund raising experts

  • Consulting and guidance

    Consulting/Guidance for faculty members to develop start-up companies and obtain non-dilutive funding

  • Coordination

    Coordination with business, marketing and design experts to develop commercialization plans, “pitch decks,” and coaching on presentation skills

  • Peter Pfanner, MDM – Director, Innovation Center, UIC
  • David Zacks, MD, PhD – Professor, University of Michigan; Chief Scientific Officer and Co-Founder, ONL Therapeutics
  • James Murray, JD – Partner, ExSight Ventures
  • Michael Nissen, MD – Partner, ExSight Ventures
  • Vinay Aakalu, MD, MPH – Past Director, ICOD3